| LCD | Title |
Effective Date |
| L39995 |
Pharmacogenomic Testing-National Government Services, Inc. |
07/13/2025 |
| L39756 |
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers-CGS Administrators, LLC |
01/01/2026 |
| L39760 |
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers-Noridian Healthcare Solutions, LLC |
01/01/2026 |
| L39764 |
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers-Noridian Healthcare Solutions, LLC |
01/01/2026 |
| L39806 |
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers-Palmetto GBA |
01/01/2026 |
| L39828 |
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers-National Government Services, Inc. |
01/01/2026 |
| L39865 |
Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers-Wisconsin Physicians Service Insurance Corporation |
01/01/2026 |
